Reuters
@Reuters·4.2M subscribers·86.9K videos
Novo Nordisk and Eli Lilly cut obesity drug prices to compete in China | REUTERS
Posted
December 30, 2025
Views
2,181
Likes
55
Engagement
2.52%
December 30, 2025
2,181
55
2.52%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:23Now PlayingNovo Nordisk and Eli Lilly lowered prices of their leading obesity drugs Wegovy and Mounjaro in China to strengthen their positions in a rapidly expanding market facing rising obesity rates. #News #Reuters #Newsfeed #novonordisk #elililly #obesity #china
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
